4//SEC Filing
MILESON GLENNA 4
Accession 0001209191-22-024219
CIK 0001620463other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 7:36 PM ET
Size
7.0 KB
Accession
0001209191-22-024219
Insider Transaction Report
Form 4
MILESON GLENNA
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-04-11−3,000→ 167,000 totalExercise: $10.64Exp: 2032-01-17→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2022-04-11$10.64/sh+3,000$31,920→ 100,060 total
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001822241
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 7:36 PM ET
- Size
- 7.0 KB